Underlying profit up 8% but development margin slipped and net debt grew NZ$322m

Net profit after tax fell 22.1% to NZ$339.8m and profit before tax dropped 15.8% to NZ$355.8m, reflecting smaller property fair-value gains rather than operational weakness. Underlying profit rose 8% to NZ$206.4m on 1,238 occupation-right sales (+12%) and revenue growth of 17.5% to NZ$319.9m.

Development margin compressed to 28.9% from 31.6%, indicating cost or pricing pressure on new units even as volumes expanded.

Operating cash flow grew 11.3% to NZ$443.2m, but capex of NZ$611.4m pushed gross borrowings 23% higher to NZ$1.7b and net debt up about NZ$322m to NZ$1.7b. The full-year dividend of 24.5 cps, including a 13.2 cps final, was unchanged from FY23.

Settlements rose 12% and revenue 17.5%, but underlying profit grew only 8% and development margin slipped roughly 270 basis points to 28.9%. This means each new unit sold is generating less margin, likely reflecting construction-cost inflation outpacing achievable settlement prices. If the gap persists, scaling delivery alone will not restore margin.

Leverage stepped up materially to fund the build pipeline. Gross borrowings rose NZ$320.8m to NZ$1.7b as capex exceeded operating cash flow by NZ$168.2m. Retirement-living balance sheets routinely carry construction debt against unsold inventory, but the widening gap between investing outflows and operating receipts raises the importance of new-sale velocity in FY25 to recycle capital.

Statutory profit overstates the operational hit. PBT and NPAT fell because fair-value gains on investment property were smaller this year, not because the operating business deteriorated. The effective tax rate remained negative (-4.5% versus -3.3% prior) due to deferred-tax credits on those revaluation movements, so PBT is the cleaner statutory read, which means the operating story is best assessed via underlying profit and development margin rather than reported NPAT.

Management commentary points to Q1 2025 settlements broadly in line with Q1 2024, contract rates up roughly 30% year to date, and 430 units under sales and resales contracts. Closing new-sale inventory is reducing toward FY20-21 levels, with management indicating about NZ$200m of additional new sales could be released as inventory normalises.

This implies sales momentum is recovering but provides no commitment on FY25 underlying profit or settlement volumes. The gap that matters is between sales activity and development margin: if margin holds around 28-29%, higher volumes will not translate proportionately into earnings, and the elevated capex programme will continue to outpace operating cash flow. A clear deleveraging path would require either margin recovery or a slower build cadence, neither of which is committed in this release.

Operating cash flow of NZ$443.2m grew 11.3% and is anchored by deferred-management-fee receipts and resident loan inflows on resales — a structural feature of retirement-village cash mechanics rather than working-capital timing. That underpins the recurring cash story.

However, free cash flow pre-lease was negative NZ$168.2m versus negative NZ$126.9m prior, a wider deficit driven by capex stepping up 16.5% to NZ$611.4m (191.1% of revenue). Headline NPAT is also flattered by historical revaluation gains in the prior comparable that were smaller this year; on the cleaner PBT measure the decline is still 15.8%, while underlying profit at NZ$206.4m grew only 8% against 12% volume growth — the operational pulse is muted relative to activity.

Trade debtor days rose to 8.3 from 6.9, a small move on the group's scale but worth noting given receivables expanded 41.9%. The recurring cash engine looks intact; the durability question is whether development margin and leverage can both stabilise without trimming the build pipeline.

This briefing cannot assess village-level occupancy, deferred-management-fee accrual trends, or the unit-level economics of resales versus new sales without the underlying segment and unit-economics disclosures.